Posted by ImproveCareNow on July 21, 2014
Boyle BM, Kappelman MD, Colletti RB, Baldassano RN, Milov DE, Crandall WV (2014). Routine use of tiopurines in maintaining remission in pediatric Crohn's disease. World Journal Gastroenterology 20(27), pg. 9185-90.
The multi-center Pediatric Inflammatory Bowel Disease Network (PIBDNet) cohort study prospectively collected data on thiopurine naïve patients initiating mercaptopurine (6MP) or azathioprine. Patients with a diagnosis of Crohn’s disease (CD) were included in our study upon entering remission as determined by physician global assessment (PGA) within 365 d of initiation of thiopurines.